Report Detail

According to our (Global Info Research) latest study, the global Gene-Edited Donor Animal Breeding System market size was valued at US$ 130 million in 2025 and is forecast to a readjusted size of US$ 629 million by 2032 with a CAGR of 25.3% during review period.
Gene-edited donor animal breeding system is an integrated breeding and quality-control platform for xenotransplantation donor animals, mainly pigs. It covers multiplex CRISPR/Cas editing, somatic cell nuclear transfer or embryo editing, SPF/DPF barrier breeding, pathogen elimination and monitoring, pedigree tracking, tissue matching, and pre-procurement release testing for donor animals supplying kidneys, hearts, livers, lungs, islets, cells, tissues, and organs. The system usually emphasizes edit stability, PERV inactivation, immune compatibility, human transgene expression, designated-pathogen control, reproductive performance, and regulatory traceability, with gross margin of about 55%.
As xenotransplantation moves from preclinical work into early clinical validation, donor animal breeding is no longer only a laboratory animal production step; it has become an upstream platform that determines organ safety, immune compatibility, and batch traceability. Demand for reliable donor sources is increasing in kidney, heart, liver, lung, and islet programs, while hospitals, translational centers, and biotechnology companies place more value on releasable, traceable, and repeatable donor animal systems.
Product upgrading is centered on multiplex gene-editing packages, PERV inactivation, designated-pathogen-free barrier breeding, and organ-specific donor lineages. Leading companies tend to integrate genome editing, cloning, animal facilities, pathogen testing, and organ procurement into closed platform capabilities, while smaller participants usually enter the market through donor-line licensing, contract breeding, and joint development for selected organs or regions.
The United States leads in clinical trials and industrialized production, while China and Japan are accelerating donor pig herd construction, DPF facilities, and clinical translation; Europe is more focused on heart programs and preclinical validation. Opportunities come from organ shortages, clearer regulatory pathways, and multi-center clinical collaboration, while risks remain in long-term immune rejection, cross-species pathogen control, animal ethics, facility investment, and differences in clinical release standards.
Report Scope
This report is a detailed and comprehensive analysis for global Gene-Edited Donor Animal Breeding System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene-Edited Donor Animal Breeding System market size and forecasts, in consumption value ($ Million), 2021-2032
Global Gene-Edited Donor Animal Breeding System market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Gene-Edited Donor Animal Breeding System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Gene-Edited Donor Animal Breeding System market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene-Edited Donor Animal Breeding System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene-Edited Donor Animal Breeding System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include eGenesis, United Therapeutics / Revivicor, Qihan Biotech, ClonOrgan, PorMedTec, Makana Therapeutics, XenoTherapeutics, XTransplant, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene-Edited Donor Animal Breeding System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Kidney Donor Animal Breeding System
Heart Donor Animal Breeding System
Liver Donor Animal Breeding System
Lung Donor Animal Breeding System
Islet and Cell Donor Animal Breeding System
Tissue Donor Animal Breeding System
Market segment by Gene Edit Package
Single-Gene Knockout Breeding System
Triple-Knockout Breeding System
Knockout and Human Transgene Breeding System
PERV-Inactivated Multi-Edit Breeding System
Custom Gene Edit Breeding System
Market segment by Pathogen Control Grade
Conventional Clean Breeding System
SPF Breeding System
DPF Breeding System
Gnotobiotic Breeding System
Clinical-Release Breeding System
Market segment by Delivery Mode
Turnkey Barrier Facility System
Modular Breeding Suite System
Contract Breeding Service System
Donor Line Licensing System
Joint Development Breeding Platform
Market segment by Application
Xenogeneic Kidney Transplantation
Xenogeneic Heart Transplantation
Xenogeneic Liver Support and Transplantation
Xenogeneic Lung Transplantation
Islet and Cell Therapy
Preclinical Safety and Compatibility Research
Market segment by players, this report covers
eGenesis
United Therapeutics / Revivicor
Qihan Biotech
ClonOrgan
PorMedTec
Makana Therapeutics
XenoTherapeutics
XTransplant
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Gene-Edited Donor Animal Breeding System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene-Edited Donor Animal Breeding System, with revenue, gross margin, and global market share of Gene-Edited Donor Animal Breeding System from 2021 to 2026.
Chapter 3, the Gene-Edited Donor Animal Breeding System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Gene-Edited Donor Animal Breeding System market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene-Edited Donor Animal Breeding System.
Chapter 13, to describe Gene-Edited Donor Animal Breeding System research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Gene-Edited Donor Animal Breeding System by Type
    • 1.3.1 Overview: Global Gene-Edited Donor Animal Breeding System Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Gene-Edited Donor Animal Breeding System Consumption Value Market Share by Type in 2025
    • 1.3.3 Kidney Donor Animal Breeding System
    • 1.3.4 Heart Donor Animal Breeding System
    • 1.3.5 Liver Donor Animal Breeding System
    • 1.3.6 Lung Donor Animal Breeding System
    • 1.3.7 Islet and Cell Donor Animal Breeding System
    • 1.3.8 Tissue Donor Animal Breeding System
  • 1.4 Classification of Gene-Edited Donor Animal Breeding System by Gene Edit Package
    • 1.4.1 Overview: Global Gene-Edited Donor Animal Breeding System Market Size by Gene Edit Package: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Gene-Edited Donor Animal Breeding System Consumption Value Market Share by Gene Edit Package in 2025
    • 1.4.3 Single-Gene Knockout Breeding System
    • 1.4.4 Triple-Knockout Breeding System
    • 1.4.5 Knockout and Human Transgene Breeding System
    • 1.4.6 PERV-Inactivated Multi-Edit Breeding System
    • 1.4.7 Custom Gene Edit Breeding System
  • 1.5 Classification of Gene-Edited Donor Animal Breeding System by Pathogen Control Grade
    • 1.5.1 Overview: Global Gene-Edited Donor Animal Breeding System Market Size by Pathogen Control Grade: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Gene-Edited Donor Animal Breeding System Consumption Value Market Share by Pathogen Control Grade in 2025
    • 1.5.3 Conventional Clean Breeding System
    • 1.5.4 SPF Breeding System
    • 1.5.5 DPF Breeding System
    • 1.5.6 Gnotobiotic Breeding System
    • 1.5.7 Clinical-Release Breeding System
  • 1.6 Classification of Gene-Edited Donor Animal Breeding System by Delivery Mode
    • 1.6.1 Overview: Global Gene-Edited Donor Animal Breeding System Market Size by Delivery Mode: 2021 Versus 2025 Versus 2032
    • 1.6.2 Global Gene-Edited Donor Animal Breeding System Consumption Value Market Share by Delivery Mode in 2025
    • 1.6.3 Turnkey Barrier Facility System
    • 1.6.4 Modular Breeding Suite System
    • 1.6.5 Contract Breeding Service System
    • 1.6.6 Donor Line Licensing System
    • 1.6.7 Joint Development Breeding Platform
  • 1.7 Global Gene-Edited Donor Animal Breeding System Market by Application
    • 1.7.1 Overview: Global Gene-Edited Donor Animal Breeding System Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Xenogeneic Kidney Transplantation
    • 1.7.3 Xenogeneic Heart Transplantation
    • 1.7.4 Xenogeneic Liver Support and Transplantation
    • 1.7.5 Xenogeneic Lung Transplantation
    • 1.7.6 Islet and Cell Therapy
    • 1.7.7 Preclinical Safety and Compatibility Research
  • 1.8 Global Gene-Edited Donor Animal Breeding System Market Size & Forecast
  • 1.9 Global Gene-Edited Donor Animal Breeding System Market Size and Forecast by Region
    • 1.9.1 Global Gene-Edited Donor Animal Breeding System Market Size by Region: 2021 VS 2025 VS 2032
    • 1.9.2 Global Gene-Edited Donor Animal Breeding System Market Size by Region, (2021-2032)
    • 1.9.3 North America Gene-Edited Donor Animal Breeding System Market Size and Prospect (2021-2032)
    • 1.9.4 Europe Gene-Edited Donor Animal Breeding System Market Size and Prospect (2021-2032)
    • 1.9.5 Asia-Pacific Gene-Edited Donor Animal Breeding System Market Size and Prospect (2021-2032)
    • 1.9.6 South America Gene-Edited Donor Animal Breeding System Market Size and Prospect (2021-2032)
    • 1.9.7 Middle East & Africa Gene-Edited Donor Animal Breeding System Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 eGenesis
    • 2.1.1 eGenesis Details
    • 2.1.2 eGenesis Major Business
    • 2.1.3 eGenesis Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.1.4 eGenesis Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 eGenesis Recent Developments and Future Plans
  • 2.2 United Therapeutics / Revivicor
    • 2.2.1 United Therapeutics / Revivicor Details
    • 2.2.2 United Therapeutics / Revivicor Major Business
    • 2.2.3 United Therapeutics / Revivicor Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.2.4 United Therapeutics / Revivicor Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 United Therapeutics / Revivicor Recent Developments and Future Plans
  • 2.3 Qihan Biotech
    • 2.3.1 Qihan Biotech Details
    • 2.3.2 Qihan Biotech Major Business
    • 2.3.3 Qihan Biotech Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.3.4 Qihan Biotech Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Qihan Biotech Recent Developments and Future Plans
  • 2.4 ClonOrgan
    • 2.4.1 ClonOrgan Details
    • 2.4.2 ClonOrgan Major Business
    • 2.4.3 ClonOrgan Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.4.4 ClonOrgan Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ClonOrgan Recent Developments and Future Plans
  • 2.5 PorMedTec
    • 2.5.1 PorMedTec Details
    • 2.5.2 PorMedTec Major Business
    • 2.5.3 PorMedTec Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.5.4 PorMedTec Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 PorMedTec Recent Developments and Future Plans
  • 2.6 Makana Therapeutics
    • 2.6.1 Makana Therapeutics Details
    • 2.6.2 Makana Therapeutics Major Business
    • 2.6.3 Makana Therapeutics Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.6.4 Makana Therapeutics Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Makana Therapeutics Recent Developments and Future Plans
  • 2.7 XenoTherapeutics
    • 2.7.1 XenoTherapeutics Details
    • 2.7.2 XenoTherapeutics Major Business
    • 2.7.3 XenoTherapeutics Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.7.4 XenoTherapeutics Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 XenoTherapeutics Recent Developments and Future Plans
  • 2.8 XTransplant
    • 2.8.1 XTransplant Details
    • 2.8.2 XTransplant Major Business
    • 2.8.3 XTransplant Gene-Edited Donor Animal Breeding System Product and Solutions
    • 2.8.4 XTransplant Gene-Edited Donor Animal Breeding System Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 XTransplant Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Gene-Edited Donor Animal Breeding System Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Gene-Edited Donor Animal Breeding System by Company Revenue
    • 3.2.2 Top 3 Gene-Edited Donor Animal Breeding System Players Market Share in 2025
    • 3.2.3 Top 6 Gene-Edited Donor Animal Breeding System Players Market Share in 2025
  • 3.3 Gene-Edited Donor Animal Breeding System Market: Overall Company Footprint Analysis
    • 3.3.1 Gene-Edited Donor Animal Breeding System Market: Region Footprint
    • 3.3.2 Gene-Edited Donor Animal Breeding System Market: Company Product Type Footprint
    • 3.3.3 Gene-Edited Donor Animal Breeding System Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Gene-Edited Donor Animal Breeding System Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Gene-Edited Donor Animal Breeding System Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Gene-Edited Donor Animal Breeding System Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Gene-Edited Donor Animal Breeding System Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Gene-Edited Donor Animal Breeding System Consumption Value by Type (2021-2032)
  • 6.2 North America Gene-Edited Donor Animal Breeding System Market Size by Application (2021-2032)
  • 6.3 North America Gene-Edited Donor Animal Breeding System Market Size by Country
    • 6.3.1 North America Gene-Edited Donor Animal Breeding System Consumption Value by Country (2021-2032)
    • 6.3.2 United States Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Gene-Edited Donor Animal Breeding System Consumption Value by Type (2021-2032)
  • 7.2 Europe Gene-Edited Donor Animal Breeding System Consumption Value by Application (2021-2032)
  • 7.3 Europe Gene-Edited Donor Animal Breeding System Market Size by Country
    • 7.3.1 Europe Gene-Edited Donor Animal Breeding System Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 7.3.3 France Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene-Edited Donor Animal Breeding System Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Gene-Edited Donor Animal Breeding System Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Gene-Edited Donor Animal Breeding System Market Size by Region
    • 8.3.1 Asia-Pacific Gene-Edited Donor Animal Breeding System Consumption Value by Region (2021-2032)
    • 8.3.2 China Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 8.3.5 India Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Gene-Edited Donor Animal Breeding System Consumption Value by Type (2021-2032)
  • 9.2 South America Gene-Edited Donor Animal Breeding System Consumption Value by Application (2021-2032)
  • 9.3 South America Gene-Edited Donor Animal Breeding System Market Size by Country
    • 9.3.1 South America Gene-Edited Donor Animal Breeding System Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene-Edited Donor Animal Breeding System Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Gene-Edited Donor Animal Breeding System Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Gene-Edited Donor Animal Breeding System Market Size by Country
    • 10.3.1 Middle East & Africa Gene-Edited Donor Animal Breeding System Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Gene-Edited Donor Animal Breeding System Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Gene-Edited Donor Animal Breeding System Market Drivers
  • 11.2 Gene-Edited Donor Animal Breeding System Market Restraints
  • 11.3 Gene-Edited Donor Animal Breeding System Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Gene-Edited Donor Animal Breeding System Industry Chain
  • 12.2 Gene-Edited Donor Animal Breeding System Upstream Analysis
  • 12.3 Gene-Edited Donor Animal Breeding System Midstream Analysis
  • 12.4 Gene-Edited Donor Animal Breeding System Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Gene-Edited Donor Animal Breeding System. Industry analysis & Market Report on Gene-Edited Donor Animal Breeding System is a syndicated market report, published as Global Gene-Edited Donor Animal Breeding System Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Gene-Edited Donor Animal Breeding System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report